Brigitte Franke-Bray (MD Ph.D.) FFPM RCP UK, Treasurer of IFAPP (www.ifapp.org) and Member of Advisory Board of ECPM (www.ecpm.ch) Basel, CH, is an independent consultant and a board-certified specialist in Pharmaceutical Medicine (PM, FMH/Switzerland). After her medical studies, she worked for several years in a German hospital (Internal Medicine, Pneumology, Allergology). After 10 years’ work as an international medical expert for respiratory diseases in Ciba-Geigy/Sandoz, Basel, Switzerland, she became the first office head/medical director for Quintiles in Switzerland and also headed two more Quintiles offices in Germany.
After about 8 years Brigitte worked as Medical Director for two Swiss companies before she joined the DIA (Drug Information Association) as the Director Europe, Middle East, Africa where she was also responsible as the global Training Director for the development of scientific congresses and training courses in Pharmaceutical Medicine which she designed in collaboration with virtually all regulatory medicines agencies on a global level. Eight years later she became a clinical reviewer with Swissmedic and finally a globally acting Medical Director in Novartis Basel, responsible for the development of medicines in respiratory diseases.
For 22 years Dr Franke-Bray was a board member of the two Swiss societies SGPM and SwAPP and organised their annual symposium for 20 years. Dr Franke-Bray is also a member of the examination committee of the University of Basel, Switzerland, for the board certification of physicians in PM as well as of various other related Basel University diplomas and certificates, e.g. for ECPM, the European Course in PM.
Dr Franke-Bray collaborated in two of the EU Commission’s IMI (Innovative Medicine Initiative) projects, PharmaTrain and EUPATI, where she deepened her knowledge of training course development in PM.
IFAPP Academy provides an online, continuing professional development course, Medical Affairs in Medicines Development, resulting in the Professional Certification, Certified Medicines Development (CMD).